Actively Recruiting
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Led by University of Washington · Updated on 2026-03-13
100
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
Sponsors
U
University of Washington
Lead Sponsor
A
Andy Hill CARE Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial compares how well a home-based personalized physical activity program (PAP) that is delivered by a digital application (app) (the ExerciseRx app) works compared to health education in improving physical activity for patients with bladder cancer that has not reached the muscle wall of the bladder (non-muscle invasive). For people who are not physically active, previous studies have shown that increasing step counts can reduce incidence of death, reduce frailty, and reduce healthcare costs. The ExerciseRx app tracks adherence to home exercise, adapts step count goals based on the patient's progress, and provides encouraging feedback and motivation from the healthcare team. Additional features include activity summaries, progress towards current goal, nudges, helpful facts about the benefits of activity, and ideas for how to incorporate daily movement. A home-based PAP using the ExerciseRx app may work better in increasing physical activity among patients with non-muscle invasive bladder cancer compared to a health education only group.
CONDITIONS
Official Title
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (age �3e= 18 years)
- Prior diagnosis of non-muscle invasive bladder cancer, currently on surveillance or receiving maintenance intravesical therapy
- Classified as insufficiently active on the Physical Activity as a Vital Sign assessment
- Has an Android or Apple smartphone or tablet
- Ambulatory
- English-speaking
- Willing and able to participate in study activities and sign the informed consent form
You will not qualify if you...
- Severe cognitive or memory impairment or dementia preventing ability to follow instructions or participate in assessments
- Inability to read or understand English
- Lack of access or insufficient facility to use an Android or iOS smart device meeting ExerciseRx app requirements
- Not receiving treatment at University of Washington
- Orthopedic, neurologic, or other problems preventing safe walking and study adherence
- Inability or unwillingness to participate in a personalized exercise program
- Current diagnosis of muscle-invasive or metastatic bladder cancer
- Uncontrolled or concurrent illnesses limiting study compliance
- Participation in another clinical trial that disallows enrollment in this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Actively Recruiting
Research Team
S
Sarah Psutka, MD, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here